Fengfei Li

5PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsPharmacogenomicsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 09, 2021
Effects of Dapagliflozin Adjunct to Insulin on Glycemic Variations in Patients with Newly Diagnosed Type 2 Diabetes: A Randomized, Controlled, Open-Labeled Trial.

Lan-Lan Jiang, Peng Zhang, Bing-Li Liu

|Aug 11, 2020
Men with Latent Autoimmune Diabetes and Type 2 Diabetes May Have Different Change Patterns in Free Testosterone.

Bo Ding, Feng-Fei Li, Xiao-Fang Zhai

|Feb 25, 2020
Sexual Differences in response to Mid- or Low-Premixed Insulin Analogue in Patients with Type 2 Diabetes.

Bing-Li Liu, Xiao-Mei Liu, Yi-Fei Ren

|Dec 25, 2019
Contributions of Fasting and Postprandial Glucose Concentrations to Haemoglobin A1c in Drug-Naïve Mal-Glucose Metabolism in Chinese Population Using Continuous Glucose Monitoring System.

Rengna Yan, Yun Hu, Fengfei Li

|May 22, 2018
Comparison of Efficacy and Safety of Lispro and Aspart Evaluated by Continuous Glucose Monitoring System in Patients with Newly Diagnosed Type 2 Diabetes.

Bing-Li Liu, Guo-Ping Yin, Feng-Fei Li

Pageof 1

Frequent Collaborators

5 joint publications

Jianhua Ma

4 joint publications

Lei Ye

3 joint publications

Yun Hu

1 joint publications

Bo Ding